Medicalgorithmics (LTS:0QR8) Other Financing: zł8.89 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QR8 Medicalgorithmics SA LTS:0QR8
70 GF Score
Price zł33.07
GF Value zł32.20
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics Other Financing?

Medicalgorithmics LTS:0QR8 70 Other Financing is zł8.89 Mil as of Mar. 2026. GuruFocus rates LTS:0QR8 with a GF Score™ of 70/100 and a GF Value™ of zł32.20. The stock has 4 warning signs investors should review.

Medicalgorithmics's Other Financing for the three months ended in Mar. 2026 was zł1.20 Mil.

Medicalgorithmics's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was zł8.89 Mil.

Medicalgorithmics Other Financing Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics Other Financing Chart

Medicalgorithmics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.05 -2.41 -1.55 -2.32 0.00

Medicalgorithmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.78 3.91 0.00 1.20
LTS:0QR8
70GF Score
Medicalgorithmics SA LTS:0QR8
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicalgorithmics Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł8.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of zł8.89 Mil mean?
Medicalgorithmics (LTS:0QR8) has a Other Financing of zł8.89 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medicalgorithmics and its competitors.
Is Medicalgorithmics' Other Financing too high?
Medicalgorithmics' current Other Financing is zł8.89 Mil. Overall, Medicalgorithmics has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Other Financing compare to ABT and SYK?
Medicalgorithmics' Other Financing of zł8.89 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Medicalgorithmics and its competitors. Medicalgorithmics's current Other Financing is zł8.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (LTS:0QR8) has a current Other Financing of zł8.89 Mil. The stock's GF Value™ is zł32.20, compared to a current price of zł33.07 — trading 2.7% above its estimated fair value. The current Other Financing is zł8.89 Mil. Medicalgorithmics' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Medicalgorithmics (LTS:0QR8), the current Other Financing is zł8.89 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (LTS:0QR8) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be overvalued. The current stock price of zł33.07 is trading 2.7% above its estimated GF Value™ of zł32.20.

Key valuation signals for LTS:0QR8:

  • Other Financing: zł8.89 Mil
  • GF Value™: zł32.20 vs. price of zł33.07 (2.7% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the LTS:0QR8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicalgorithmics Business Description

Other Exchanges MDG:Poland
Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
70GF Score

Get the complete analysis for LTS:0QR8

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł33.07
Price
zł32.20
GF Value